PTPA and cancer: These findings corroborated previous observations regarding the additive anti-cancer effect, on chronic myeloid leukemia stem cells, of the inhibition of TKs and JAK2, which is a component of the PP2A/β-catenin/BCR-ABL complex (Lin et al., 2014).